Kvantify
Kvantify is a quantum computing software company that develops algorithms coupling quantum and classical computing to solve challenging problems in chemistry and biology for molecular discovery and drug development. The company's software runs on both quantum computers and classical compute architectures including CPUs and GPUs, distributing calculations across the appropriate quantum or classical compute…
Funding snapshot
About
Kvantify is a quantum computing software company that develops algorithms coupling quantum and classical computing to solve challenging problems in chemistry and biology for molecular discovery and drug development. The company's software runs on both quantum computers and classical compute architectures including CPUs and GPUs, distributing calculations across the appropriate quantum or classical compute infrastructure in high-performance computing environments. Kvantify's approach leverages the quantum computer as the ultimate precision machine for describing molecular properties through quantum chemistry theory, while using classical computing to build AI and physics-based models that cover large chemical and biological spaces. This coupling strategy prepares for the near future when quantum computers outperform classical computers in molecular simulation, while delivering practical value today by combining the speed and accuracy of quantum computing with the power of classical computing clouds. The company provides off-the-shelf, sector-specific solutions for the financial services and life sciences industries, democratizing access to advanced computing technology. Kvantify's software algorithms are designed to intelligently route computational workloads between quantum and classical processors, optimizing for both accuracy and throughput in drug discovery pipelines. Founded in 2022 and headquartered in Copenhagen, Denmark, Kvantify has raised $18.9M in Seed funding from investors including EIC Fund, Dreamcraft Ventures, Lundbeck Foundation, 2degrees, Redstone, 2xN, Danmarks Eksport og Investeringsfond, Europa, Delphinus Venture Capital, QAi Ventures, and QAI Capital.
Business model
Quantum Computing > Quantum Software > Computational Platforms,
Life Sciences Tech > Research & Development > Drug Discovery > Cheminformatics > Lead Discovery
Team background
Company Wise > McKinsey
Institutional investors
Latest coverage
No articles yet.
Similar startups
NovaHealth AI
NovaHealth AI automates visit summaries, coding suggestions, and prior-authorization drafts for mid-sized provider groups.
ScreenPoint
Developer of artificial intelligence software for analyzing breast imaging mammograms. This technology integrates with existing medical imaging hardware to assist radiologists in detecting cancer.
Bioz
Developer of AI search engine for scientific experimentation.
Rad AI
Developer of radiology artificial intelligence software for workflow and reporting. The software aims to improve efficiency and reduce fatigue for radiologists.